A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
Article in Pharmaceutical Research (May 2021)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
A Critical Overview of Systematic Reviews of Chemotherapy for Advanced and Locally Advanced Pancreatic Cancer using both AMSTAR2 and ROBIS as Quality Assessment Tools.
Article in Reviews on Recent Clinical Trials (January 2021)
Prolonged Infusion of Low Dose Gemcitabine in Advanced Pancreatic Carcinoma
Article in Journal of Cancer Therapy (July 2020)